An advisory panel to the U.S. Food and Drug Administration (FDA) recommended that the opioid reversal nasal spray Narcan should become an over-the-counter drug.
Narcan, or naxolone, is the most commonly sold medication to deal with opioid overdoses. Emergent BioSolutions Inc. submitted an application to the FDA late last year to allow it to sell generic naloxone hydrochloride without a prescription.
“There is no reason to keep this as a prescription, let’s get it out there and save some lives,” said Elizabeth Coykendall, a paramedic and temporary voting member of the FDA committee, in the panel meeting on Wednesday….